| 000 | 01826 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514164427.0 | ||
| 264 | 0 | _c20050103 | |
| 008 | 200501s 0 0 eng d | ||
| 022 | _a1619-7070 | ||
| 024 | 7 |
_a10.1007/s00259-003-1389-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReimold, M | |
| 245 | 0 | 0 |
_aNon-invasive assessment of distribution volume ratios and binding potential: tissue heterogeneity and interindividually averaged time-activity curves. _h[electronic resource] |
| 260 |
_bEuropean journal of nuclear medicine and molecular imaging _cApr 2004 |
||
| 300 |
_a564-77 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Validation Study | ||
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 |
_aCorpus Striatum _xdiagnostic imaging |
| 650 | 0 | 4 | _aDiagnostic Techniques, Radioisotope |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImage Enhancement |
| 650 | 0 | 4 |
_aImage Interpretation, Computer-Assisted _xmethods |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aModels, Statistical |
| 650 | 0 | 4 |
_aParkinson Disease _xdiagnostic imaging |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aRaclopride _xpharmacokinetics |
| 650 | 0 | 4 | _aRadionuclide Imaging |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacokinetics |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aMueller-Schauenburg, W | |
| 700 | 1 | _aBecker, G A | |
| 700 | 1 | _aReischl, G | |
| 700 | 1 | _aDohmen, B M | |
| 700 | 1 | _aBares, R | |
| 773 | 0 |
_tEuropean journal of nuclear medicine and molecular imaging _gvol. 31 _gno. 4 _gp. 564-77 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00259-003-1389-5 _zAvailable from publisher's website |
| 999 |
_c14420579 _d14420579 |
||